Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma.
Zhu YT, Wu SY, Yang S, Ying J, Tian L, Xu HL, Zhang HP, Yao H, Zhang WY, Jin QQ, Yang YT, Jiang XY, Zhang N, Yao S, Zhou SG, Chen G.
Zhu YT, et al. Among authors: zhang n, zhang hp, zhang wy.
Heliyon. 2023 Jul 26;9(8):e18708. doi: 10.1016/j.heliyon.2023.e18708. eCollection 2023 Aug.
Heliyon. 2023.
PMID: 37554782
Free PMC article.